the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
June 17, 2015 – Bristol Myers Squipp recently announced that the U.S. Food and Drug Administration (FDA) has approved Nivolumab (Opdivo) injection, for intravenous use, for the treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on …
May 09, 2015 – The U.S. Food and Drug Administration (FDA) recently approved Kybella (deoxycholic acid) as treatment for adults with moderate-to-severe fat below the chin, known as submental fat (i.e., located in the submental triangle). Using Kybella for the …
January 30, 2015 – We just learned that the U.S. Food and Drug Administration expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults. The drug is the first FDA-approved medication to treat this condition. In binge-eating …
FDA expands uses of Vyvanse (Lisdexamfetamine Dimesylate) to treat Binge-Eating Disorder Read more »
January 23, 2015 – The U.S. Food and Drug Administration today allowed marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor (CGM) with other people …
January 21, 2015 – On this day, the U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is an …
January 17, 2015 – The following post is an excerpt from a recent (December 30, 2014) publication by Janet Woodcock, M.D., on FDA Voice. She talks about the FDA’s upcoming Sentinel System, which will have a huge impact on how in future …
Full Scale “Active Surveillance”: The Sentinel System Read more »
December 12, 2014 – The American Food & Drug Administration (FDA) has recently issued a warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin reaction that can …
Rare But Potentially Fatal Skin Reactions (DRESS Syndrome) with Ziprasidone [Geodon] Read more »
October 23, 3014 – Pulmonary fibrosis is a disease in which tissue deep inside the lungs becomes thick, stiff, and scarred, decreasing the lungs’ ability to expand to take in air, and making it difficult to breathe. This is a …
FDA approved two drugs for idiopathic pulmonary fibrosis (IPF) Read more »
October 12, 2014 – The U.S. Food and Drug Administration, on October 10, approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy. Akynzeo is a fixed combination capsule comprised of two drugs. Oral palonosetron approved …
October 05, 2014 – To strengthen the safety of medical devices, the U.S. Food and Drug Administration has finalised and released recommendations to manufacturers for managing cybersecurity risks to better protect patient health and information. The final guidance, titled “Content …
Steps to strengthen cybersecurity of medical devices Read more »